Increasing our understanding ofpigmentary disorders
Pearl Grimes, MD,a James J. Nordlund, MD,b Amit G. Pandya, MD,c Susan Taylor, MD,d
Marta Rendon, MD,e and Jean-Paul Ortonne, MDf
Los Angeles, California; Dayton and Mason, Ohio; Dallas, Texas;
New York, New York; Boca Raton, Florida; and Nice, France
This article focuses on developments in pigmentary disorders that extend dermatologists' understanding of the field. Areas that are reviewed include the basic biochemistry, pharmacology, and physiology of the melanocortin system; melanosome development; genetic diseases associated with pigmentary disorders; pigmentary disorders secondary to systemic disease; drug-induced hyperpigmentation; environmental exposure to chemicals; and primary disorders of hyperpigmentation such as melasma and lentigines.
Basic, clinical, and epidemiological research, along with a number of clinical case reports, were included in the review. This article also reports on the new health-related quality-of-life instrument (MELASQOL) that has been developed for women with melasma. ( J Am Acad Dermatol 2006;54:S255-61.)
 |
Increasing our understanding of pigmentary disorders.pdf 160K Descargar documento |
Escrito por Antonio Rondon Lugo el 24 de enero de 2007 con
1 comentario.
Lee más artículos sobre Articulos cientificos
